Trulieve Faces Lawsuit Over Employee Firings in Florida

Dec.14.2022
Trulieve Faces Lawsuit Over Employee Firings in Florida
Trulieve, a multi-state marijuana operator based in Florida, faces a collective lawsuit for allegedly not providing adequate notice prior to employee layoffs.

Trulieve, a multi-state cannabis operator headquartered in Florida, recently terminated some of its employees in Gadsden County. This resulted in affected workers filing a collective lawsuit alleging that the company did not provide sufficient notice before their termination.


Trulieve, a Florida-based cannabis company, operates two cultivation sites in Quincy and a processing plant on Midway Island in Gadsden County. The company has not disclosed the number of employees who have been terminated but has stated that the move is aimed at reducing layoffs as the company continues to grow, according to the Tallahassee Democrat.


According to Trulieve spokesperson Steve Vancore, affected employees have been offered alternative jobs at the company's other factories in Jefferson and Madison counties. Those employees who were ultimately not able to secure another position will receive severance pay.


Vancore informed Democratic lawmakers in Tallahassee that the layoffs ultimately stemmed from Trulieve's acquisition of Harvest Health and Recreation, which is based in Arizona.


We merged and acquired Harvest a year ago," Vancore told the news media. "This was part of our consolidation strategy as we continue to develop in areas of redundancy and inefficiency. When you have 9,000 employees, this is indeed a measure to improve efficiency.


Last week, employees affected by layoffs filed a class-action lawsuit against Trulieve, alleging that the company failed to provide the required Worker Adjustment and Retraining Notification (WARN) Act notice regarding their termination.


According to Democrats in Tallahassee, the lawsuit alleges that if a company lays off "50 or more employees (excluding any part-time employees) at a single worksite within any 30-day period," it must provide a notice under the WARN Act.


According to a report by the Tampa Bay Times, the lawsuit was originally filed by attorney Tiffany Cruz on behalf of Langel O'Neil, who worked at Trulieve's Quincy facility. The plaintiff is seeking monetary compensation equivalent to the total amount of unpaid wages, salaries, commissions, bonuses, accrued vacation pay, accrued sick pay, and other benefits within 60 days after termination. This has been reported in the media.


Trulieve has contested these allegations, according to Tallahassee attorney and partner at Stearns Weaver Miller, Glenn Burhans Jr., who told the news media that Trulieve "has complied with all state and federal laws regarding the reduction of force.


In possible scenarios, Trulieve offers affected employees new positions at the same location or other locations within the area," he told the Tampa Bay Times. "If relocation is not feasible or not accepted, employees will receive severance pay.


In another statement provided to the news media, Trulieve expressed its commitment to the northwest region of Florida and highlighted the construction of a 750,000-square-foot facility in Jefferson County by the company.


According to a statement released by the company to the Tampa Bay Times, Trulieve has approximately 9,000 employees in the United States and is currently hiring for "additional positions in various fields".



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14